No abstract available
MeSH terms
-
Adenocarcinoma / drug therapy*
-
Adenocarcinoma / radiotherapy*
-
Androgen Antagonists / therapeutic use*
-
Antineoplastic Agents, Hormonal / therapeutic use*
-
Chemotherapy, Adjuvant
-
Combined Modality Therapy
-
Humans
-
Male
-
Patient Selection
-
Prostatic Neoplasms / drug therapy*
-
Prostatic Neoplasms / radiotherapy*
-
Radiotherapy Dosage
-
Randomized Controlled Trials as Topic
-
Survival Rate
-
Time Factors
Substances
-
Androgen Antagonists
-
Antineoplastic Agents, Hormonal